Group One Trading
VOR icon

Group One Trading’s Vor Biopharma VOR Stock Holding History

Group One Trading’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$919K Sell
51,500
-133,500
-72% -$1.88M ﹤0.01% 2805
2025
Q4 		$2.42M Sell
185,000
-1,876,900
-91% -$34.9M ﹤0.01% 2111
2025
Q3 		$100M Buy
2,061,900
+1,991,405
+2,825% +$80.1M 0.18% 91
2025
Q2 		$2.28M Buy
70,495
+68,545
+3,515% +$606K 0.01% 2006
2025
Q1 		$28K Sell
1,950
-520
-21% -$12.5K ﹤0.01% 5590
2024
Q4 		$54.8K Buy
2,470
+1,975
+399% +$32.7K ﹤0.01% 4983
2024
Q3 		$6.93K Sell
495
-210
-30% -$3.83K ﹤0.01% 5762
2024
Q2 		$14.1K Hold
705
– – ﹤0.01% 5446
2024
Q1 		$33.4K Buy
+705
New +$31K ﹤0.01% 5039
2023
Q4 		– Sell
-100
Closed -$4.24K – 8258
2023
Q3 		$4.24K Buy
+100
New +$5.42K ﹤0.01% 6779
2023
Q2 		– Sell
-55
Closed -$5.92K – 8262
2023
Q1 		$5.92K Sell
55
-90
-62% -$9.97K ﹤0.01% 6208
2022
Q4 		$19.3K Buy
+145
New +$14.3K ﹤0.01% 5622

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's VOR Position: Q1 2026 in Review

Group One Trading opened a new position in Vor Biopharma (VOR) in Q1 2026: 9,065 shares worth $162K. The stake represents ﹤0.01% of the portfolio and ranks #4295 among its holdings. This is a return to the name: Group One Trading previously reported a position in VOR as recently as Q1 2025.

Group One Trading first reported a position in VOR in Q4 2023 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Group One Trading held 9,065 shares of Vor Biopharma worth $162K as of Q1 2026.
  • Vor Biopharma was a new Group One Trading position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4295 holding.
  • Group One Trading first reported a position in Vor Biopharma in Q4 2023 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.